Seres Therapeutics Reports Second Quarter 2017 Financial Results and Provides Update on Operational Progress
Go back to Seres Therapeutics Reports Second Quarter 2017 Financial Results and Provides Update on Operational Progress| (NASDAQ: MCRB) | Delayed: 6.60 -0.01 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.61 | 52 Week High | $44.51 | |||
| Open | $6.68 | 52 Week Low | $8.05 | |||
| Day High | $7.05 | P/E | N/A | |||
| Day Low | $6.31 | EPS | $0.00 | |||
| Volume | 81,636 | |||||
| Nestle SA Sponsored ADR representing Registered Shares Series B (AMEX: NSRGY) | Delayed: 97.33 -0.77 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.10 | 52 Week High | $83.25 | |||
| Open | $97.61 | 52 Week Low | $67.73 | |||
| Day High | $98.10 | P/E | N/A | |||
| Day Low | $97.00 | EPS | $0.00 | |||
| Volume | 456,293 | |||||
